BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 151 filers reported holding BLUEBIRD BIO INC in Q2 2024. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $736,385 | -65.1% | 748,299 | -54.6% | 0.00% | -100.0% |
| Q1 2024 | $2,108,859 | -49.0% | 1,647,546 | -45.0% | 0.00% | 0.0% |
| Q4 2023 | $4,133,569 | -19.5% | 2,995,274 | +77.4% | 0.00% | -50.0% |
| Q3 2023 | $5,133,297 | +12.7% | 1,688,583 | +21.9% | 0.00% | +100.0% |
| Q2 2023 | $4,555,910 | -44.8% | 1,384,820 | -46.7% | 0.00% | -66.7% |
| Q1 2023 | $8,256,667 | +58884.6% | 2,596,469 | +28.4% | 0.00% | -25.0% |
| Q4 2022 | $13,998 | -99.9% | 2,022,807 | +33.8% | 0.00% | 0.0% |
| Q3 2022 | $9,570,000 | +422.1% | 1,512,283 | +241.9% | 0.00% | +300.0% |
| Q2 2022 | $1,833,000 | -41.8% | 442,277 | -31.9% | 0.00% | 0.0% |
| Q1 2022 | $3,150,000 | -30.5% | 649,514 | +43.1% | 0.00% | 0.0% |
| Q4 2021 | $4,535,000 | -29.6% | 453,869 | +34.6% | 0.00% | -50.0% |
| Q3 2021 | $6,445,000 | -28.1% | 337,248 | +20.2% | 0.00% | -33.3% |
| Q2 2021 | $8,967,000 | +0.0% | 280,509 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $8,963,000 | -43.4% | 297,372 | -18.7% | 0.00% | -50.0% |
| Q4 2020 | $15,828,000 | -19.5% | 365,749 | +0.4% | 0.01% | -25.0% |
| Q3 2020 | $19,656,000 | +2.7% | 364,311 | +16.2% | 0.01% | 0.0% |
| Q2 2020 | $19,135,000 | +84.0% | 313,527 | +38.6% | 0.01% | +60.0% |
| Q1 2020 | $10,399,000 | -41.6% | 226,243 | +11.5% | 0.01% | -16.7% |
| Q4 2019 | $17,813,000 | -5.1% | 202,999 | -0.7% | 0.01% | -14.3% |
| Q3 2019 | $18,775,000 | -24.0% | 204,454 | +5.3% | 0.01% | -30.0% |
| Q2 2019 | $24,702,000 | -6.4% | 194,241 | +15.8% | 0.01% | -9.1% |
| Q1 2019 | $26,383,000 | +67.3% | 167,737 | +5.5% | 0.01% | +57.1% |
| Q4 2018 | $15,774,000 | -19.2% | 159,023 | +18.9% | 0.01% | 0.0% |
| Q3 2018 | $19,521,000 | -5.4% | 133,711 | +1.7% | 0.01% | -12.5% |
| Q2 2018 | $20,640,000 | -16.6% | 131,520 | -9.3% | 0.01% | -20.0% |
| Q1 2018 | $24,746,000 | -5.0% | 144,926 | -0.9% | 0.01% | -9.1% |
| Q4 2017 | $26,053,000 | +35.5% | 146,275 | +4.5% | 0.01% | +37.5% |
| Q3 2017 | $19,231,000 | +72.4% | 139,994 | +31.8% | 0.01% | +60.0% |
| Q2 2017 | $11,158,000 | +44.5% | 106,189 | +25.0% | 0.01% | +25.0% |
| Q1 2017 | $7,723,000 | +83.4% | 84,961 | +24.5% | 0.00% | +100.0% |
| Q4 2016 | $4,210,000 | -8.2% | 68,220 | +0.8% | 0.00% | 0.0% |
| Q3 2016 | $4,586,000 | +49.8% | 67,680 | -4.3% | 0.00% | 0.0% |
| Q2 2016 | $3,061,000 | -2.0% | 70,722 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $3,122,000 | -35.0% | 73,510 | -1.8% | 0.00% | -33.3% |
| Q4 2015 | $4,806,000 | -20.2% | 74,831 | +6.3% | 0.00% | -25.0% |
| Q3 2015 | $6,022,000 | -20.7% | 70,377 | +55.9% | 0.00% | -20.0% |
| Q2 2015 | $7,597,000 | +93.5% | 45,144 | +38.9% | 0.01% | +150.0% |
| Q1 2015 | $3,926,000 | – | 32,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |